placebo with matching volume

DRUG3 trials

Sponsors

Hangzhou Sciwind Biosciences Co., Ltd.

Conditions

OSA - Obstructive Sleep ApneaObese AdolescentsObesity

Phase 1

A Study of XW003 Injection in Chinese Adolescents With Obesity

CompletedNCT07143227

Hangzhou Sciwind Biosciences Co., Ltd.Obese Adolescents, Obesity

Start: 2025-08-25End: 2026-04-18Updated: 2026-05-20

Phase 3

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

RecruitingNCT07387094

Hangzhou Sciwind Biosciences Co., Ltd.Obesity, OSA - Obstructive Sleep Apnea

Start: 2026-02-09End: 2027-12-16Target: 140Updated: 2026-04-14

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

RecruitingNCT07434050

Hangzhou Sciwind Biosciences Co., Ltd.Obesity, OSA - Obstructive Sleep Apnea

Start: 2026-03-02End: 2028-06-19Target: 140Updated: 2026-04-13